Research suggests that up to 57% of prostate cancer is attributable to genetic risk factors. Our genomic (genetic) testing can ensure you and your treating clinician are more informed about what your prostate cancer and risk for the next 10 years looks like. This allows you to make a more informed treatment plan.

Testing may also inform you and your family if there is a heritable aspect to your disease and if your relatives need to be tested as well. This testing will occur at no additional cost to you or your care provider.